Search research articles
Contact Us
Filters
Showing results (71-80 of 119) with videos related to
Page
of 12
Sort By:
BMC Cancer
|
October 16, 2015
Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study
S Rahal, J M Boher, J M Extra, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T Valentin, A Le Cesne, I Ray-Coquard, et al.
Oncogene
|
September 28, 2005
Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy
A Gonçalves, B Esterni, F Bertucci, et al.
Oncogene
|
May 21, 2008
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles
F Bertucci, B Orsetti, V Nègre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2012
Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients
F Bertucci, P Finetti, H Roche, et al.
Acta Gastro-Enterologica Belgica
|
March 22, 2018
Patients with primary localized high-grade sarcomas of the digestive tract excluding GIST : a retrospective study from the French sarcoma group
A de Nonneville, C Toullec, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 24, 2015
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)
E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
Surgical Oncology
|
June 15, 2019
Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients
C Honoré, J B Delhorme, E Nassif, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2016
Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer
M M-Rabet, O Cabaud, E Josselin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2025
Corrigendum to "Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)": [Ann Oncol 26 (2015) 2168-2173]
E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 119) with videos related to
Sort By:
Page
of 12
BMC Cancer
|
October 16, 2015
Immunohistochemical subtypes predict the clinical outcome in high-risk node-negative breast cancer patients treated with adjuvant FEC regimen: results of a single-center retrospective study
S Rahal, J M Boher, J M Extra, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 30, 2016
Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)
T Valentin, A Le Cesne, I Ray-Coquard, et al.
Oncogene
|
September 28, 2005
Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy
A Gonçalves, B Esterni, F Bertucci, et al.
Oncogene
|
May 21, 2008
Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles
F Bertucci, B Orsetti, V Nègre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2012
Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients
F Bertucci, P Finetti, H Roche, et al.
Acta Gastro-Enterologica Belgica
|
March 22, 2018
Patients with primary localized high-grade sarcomas of the digestive tract excluding GIST : a retrospective study from the French sarcoma group
A de Nonneville, C Toullec, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 24, 2015
Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)
E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
Surgical Oncology
|
June 15, 2019
Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients
C Honoré, J B Delhorme, E Nassif, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 22, 2016
Nectin-4: a new prognostic biomarker for efficient therapeutic targeting of primary and metastatic triple-negative breast cancer
M M-Rabet, O Cabaud, E Josselin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 16, 2025
Corrigendum to "Sorafenib in patients with locally advanced and metastatic chordomas: a phase II trial of the French Sarcoma Group (GSF/GETO)": [Ann Oncol 26 (2015) 2168-2173]
E Bompas, A Le Cesne, E Tresch-Bruneel, et al.
Page
of 12